In addition, it is significantly increased in vascular lesions and the kidneys of patients with hyperglycemia and/or hyperlipidemia, suggesting the dysregulation of CD36 levels in obesity and related metabolic dysfunction [38]. The gene discussed is CD36; the disease is Hyperglycemia.